Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electromyography | 1 | 2019 | 61 | 0.680 |
Why?
|
| Rehabilitation | 1 | 2019 | 3 | 0.670 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2019 | 111 | 0.650 |
Why?
|
| Frail Elderly | 1 | 2019 | 70 | 0.630 |
Why?
|
| Adhesins, Bacterial | 1 | 2015 | 3 | 0.520 |
Why?
|
| Leptospira | 1 | 2015 | 3 | 0.520 |
Why?
|
| Bacterial Adhesion | 1 | 2015 | 8 | 0.520 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 514 | 0.500 |
Why?
|
| Aging | 1 | 2019 | 953 | 0.410 |
Why?
|
| PPAR gamma | 1 | 2012 | 47 | 0.400 |
Why?
|
| Lipids | 1 | 2012 | 226 | 0.370 |
Why?
|
| Neoplasms | 1 | 2012 | 695 | 0.250 |
Why?
|
| Humans | 6 | 2019 | 32297 | 0.130 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2015 | 9 | 0.130 |
Why?
|
| Leptospirosis | 1 | 2015 | 5 | 0.130 |
Why?
|
| Cell Line | 1 | 2015 | 462 | 0.120 |
Why?
|
| Fatty Acids, Volatile | 1 | 2010 | 10 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4050 | 0.090 |
Why?
|
| Receptors, Steroid | 1 | 2010 | 8 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 73 | 0.090 |
Why?
|
| Colon | 1 | 2010 | 52 | 0.090 |
Why?
|
| Camptothecin | 1 | 2010 | 53 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 73 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 38 | 0.090 |
Why?
|
| Disease Progression | 1 | 2012 | 618 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1040 | 0.080 |
Why?
|
| Aged | 1 | 2019 | 10398 | 0.060 |
Why?
|
| Male | 1 | 2019 | 19488 | 0.050 |
Why?
|
| Female | 1 | 2019 | 20126 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 264 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2010 | 305 | 0.040 |
Why?
|
| Animals | 1 | 2012 | 7694 | 0.040 |
Why?
|
| Acetylation | 1 | 2010 | 16 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 42 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 54 | 0.020 |
Why?
|
| Histones | 1 | 2010 | 54 | 0.020 |
Why?
|
| Nifedipine | 1 | 2010 | 9 | 0.020 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2010 | 5 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2010 | 33 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 19 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2010 | 37 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 33 | 0.020 |
Why?
|
| Plasmids | 1 | 2010 | 52 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 187 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 96 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 213 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2010 | 78 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 95 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2010 | 142 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 301 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 534 | 0.020 |
Why?
|
| Apoptosis | 1 | 2010 | 368 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 602 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 846 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 315 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 502 | 0.020 |
Why?
|